Literature DB >> 25128167

Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function.

Amit Saxena1, Marcin Dobaczewski1, Vikrant Rai1, Zaffar Haque1, Wei Chen1, Na Li1, Nikolaos G Frangogiannis2.   

Abstract

Regulatory T cells (Tregs) play a pivotal role in suppressing immune responses regulating behavior and gene expression in effector T cells, macrophages, and dendritic cells. Tregs infiltrate the infarcted myocardium; however, their role the inflammatory and reparative response after myocardial infarction remains poorly understood. We used FoxP3(EGFP) reporter mice to study Treg trafficking in the infarcted heart and examined the effects of Treg depletion on postinfarction remodeling using an anti-CD25 antibody. Moreover, we investigated the in vitro effects of Tregs on cardiac fibroblast phenotype and function. Low numbers of Tregs infiltrated the infarcted myocardium after 24-72 h of reperfusion. Treg depletion had no significant effects on cardiac dysfunction and scar size after reperfused myocardial infarction but accelerated ventricular dilation and accentuated apical remodeling. Enhanced myocardial dilation in Treg-depleted animals was associated with increased expression of chemokine (C-C motif) ligand 2 and accentuated macrophage infiltration. In vitro, Tregs modulated the cardiac fibroblast phenotype, reducing expression of α-smooth muscle actin, decreasing expression of matrix metalloproteinase-3, and attenuating contraction of fibroblast-populated collagen pads. Our findings suggest that endogenous Tregs have modest effects on the inflammatory and reparative response after myocardial infarction. However, the anti-inflammatory and matrix-preserving properties of Tregs may suggest a role for Treg-based cell therapy in the attenuation of adverse postinfarction remodeling.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  fibroblast; inflammation; lymphocyte; myocardial infarction; remodeling

Mesh:

Substances:

Year:  2014        PMID: 25128167      PMCID: PMC4200341          DOI: 10.1152/ajpheart.00328.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  39 in total

1.  Human CD4+CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation.

Authors:  Roch Houot; Ivan Perrot; Eric Garcia; Isabelle Durand; Serge Lebecque
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

Review 2.  Regulatory T cells and immune tolerance.

Authors:  Shimon Sakaguchi; Tomoyuki Yamaguchi; Takashi Nomura; Masahiro Ono
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

3.  CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.

Authors:  Oliver Dewald; Pawel Zymek; Kim Winkelmann; Anna Koerting; Guofeng Ren; Tareq Abou-Khamis; Lloyd H Michael; Barrett J Rollins; Mark L Entman; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2005-03-17       Impact factor: 17.367

4.  The histopathologic evolution of myocardial infarction.

Authors:  M C Fishbein; D Maclean; P R Maroko
Journal:  Chest       Date:  1978-06       Impact factor: 9.410

5.  CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Erin E West; Matthew H Willett; Martin F Britos; Matthew R Pipeling; Roy G Brower; Rubin M Tuder; John F McDyer; Landon S King
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 6.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

7.  The inhibitory cytokine IL-35 contributes to regulatory T-cell function.

Authors:  Lauren W Collison; Creg J Workman; Timothy T Kuo; Kelli Boyd; Yao Wang; Kate M Vignali; Richard Cross; David Sehy; Richard S Blumberg; Dario A A Vignali
Journal:  Nature       Date:  2007-11-22       Impact factor: 49.962

8.  Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.

Authors:  Marcin Bujak; Guofeng Ren; Hyuk Jung Kweon; Marcin Dobaczewski; Anilkumar Reddy; George Taffet; Xiao-Fan Wang; Nikolaos G Frangogiannis
Journal:  Circulation       Date:  2007-10-22       Impact factor: 29.690

9.  Dendritic cells in the hearts of spontaneously hypertensive rats treated with doxorubicin with or without ICRF-187.

Authors:  J Zhang; E H Herman; V J Ferrans
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

10.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions.

Authors:  Matthias Nahrendorf; Filip K Swirski; Elena Aikawa; Lars Stangenberg; Thomas Wurdinger; Jose-Luiz Figueiredo; Peter Libby; Ralph Weissleder; Mikael J Pittet
Journal:  J Exp Med       Date:  2007-11-19       Impact factor: 14.307

View more
  77 in total

1.  Increasing Regulatory T Cells With Interleukin-2 and Interleukin-2 Antibody Complexes Attenuates Lung Inflammation and Heart Failure Progression.

Authors:  Huan Wang; Lei Hou; Dongmin Kwak; John Fassett; Xin Xu; Angela Chen; Wei Chen; Bruce R Blazar; Yawei Xu; Jennifer L Hall; Jun-Bo Ge; Robert J Bache; Yingjie Chen
Journal:  Hypertension       Date:  2016-05-09       Impact factor: 10.190

Review 2.  The role of transforming growth factor (TGF)-β in the infarcted myocardium.

Authors:  Nikolaos G Frangogiannis
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

3.  Extracellular ubiquitin modulates cardiac fibroblast phenotype and function via its interaction with CXCR4.

Authors:  Stephanie L C Scofield; Christopher R Daniels; Suman Dalal; Jonathan A Millard; Mahipal Singh; Krishna Singh
Journal:  Life Sci       Date:  2018-09-05       Impact factor: 5.037

Review 4.  Tissue Tregs.

Authors:  Marisella Panduro; Christophe Benoist; Diane Mathis
Journal:  Annu Rev Immunol       Date:  2016-05-20       Impact factor: 28.527

5.  Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.

Authors:  Shyam S Bansal; Mohamed Ameen Ismahil; Mehak Goel; Guihua Zhou; Gregg Rokosh; Tariq Hamid; Sumanth D Prabhu
Journal:  Circulation       Date:  2019-01-08       Impact factor: 29.690

6.  mTORC1 signaling is crucial for regulatory T cells to suppress macrophage-mediated inflammatory response after acute myocardial infarction.

Authors:  Keping Yang; Yunfeng Zhang; Chenhong Xu; Xin Li; Dazhu Li
Journal:  Immunol Cell Biol       Date:  2015-10-06       Impact factor: 5.126

7.  Regulating heart repair with cardiac-specific T lymphocytes.

Authors:  Ziad Mallat
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

Review 8.  Immune cell diversity contributes to the pathogenesis of myocarditis.

Authors:  Xiumeng Hua; Jiangping Song
Journal:  Heart Fail Rev       Date:  2019-11       Impact factor: 4.214

Review 9.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

10.  Cell biological mechanisms in regulation of the post-infarction inflammatory response.

Authors:  Nikolaos G Frangogiannis
Journal:  Curr Opin Physiol       Date:  2017-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.